Improved asthma diagnosis using two tests in combination

It was previously thought that the two test methods signalled the same type of asthma. But a new study, led by researchers at Uppsala University, Sweden, shows that the methods actually signal two different inflammatory processes. With the tests used in combination, the chances are probably greater for the patient to receive just the right treatment...

In children exposed to diesel exhaust from traffic, protein explains increased asthma severity

A new study shows that exposure to diesel exhaust particles from traffic pollution leads to increased asthma severity in children. Moreover, the study finds that this is due to increased blood levels of IL-17A, a protein associated with several chronic inflammatory diseases, in children with high diesel exposure...

Gene’s contribution to asthma susceptibility revealed

New research from the University of Minnesota College of Veterinary Medicine (CVM) has uncovered the role gene ORMDL3 plays in the disease asthma. ORMDL3, a gene recently linked to asthma susceptibility, has now been linked to the body's ability to recruit inflammatory cells during an airway allergic reaction. Study findings appear today in the journal Nature Communications...

Gene’s contribution to asthma susceptibility revealed

New research from the University of Minnesota College of Veterinary Medicine (CVM) has uncovered the role gene ORMDL3 plays in the disease asthma. ORMDL3, a gene recently linked to asthma susceptibility, has now been linked to the body's ability to recruit inflammatory cells during an airway allergic reaction. Study findings appear today in the journal Nature Communications...

RELVAR™ ELLIPTA™ receives regulatory approval in Japan

Skyepharma PLC (LSE: SKP), the expert oral and inhalation drug delivery company, announces that the regulatory committee (Bunka-Kai) of the Japanese Ministry of Health, Labour and Welfare ("MHLW") has approved RELVARTM ELLIPTATM (FF/VI) for the treatment of bronchial asthma (in cases where concurrent use of inhaled corticosteroid and long- acting inhaled beta2 agonist is required)...